Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Amgen Inc. (NASDAQ:AMGN)

Balance Sheet: Assets

Beginner level

The balance sheet provides creditors, investors, and analysts with information on company’s resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company’s assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Amgen Inc., consolidated balance sheet: assets

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Cash and cash equivalents 6,266  6,037  6,945  3,800  3,241 
Marketable securities 4,381  2,874  22,359  37,878  34,844 
Trade receivables, net 4,525  4,057  3,580  3,237  3,165 
Inventories 3,893  3,584  2,940  2,834  2,745 
Prepaid expenses 1,156  939  907  —  — 
Corporate partner receivables 583  485  444  —  — 
Tax receivables 216  186  —  —  — 
Other 124  278  443  1,727  2,015 
Other current assets 2,079  1,888  1,794  1,727  2,015 
Current assets 21,144  18,440  37,618  49,476  46,010 
Property, plant and equipment, net 4,889  4,928  4,958  4,989  4,961 
Intangible assets, net 16,587  19,413  7,443  8,609  10,279 
Goodwill 14,689  14,703  14,699  14,761  14,751 
Other assets 5,639  2,223  1,698  2,119  1,625 
Noncurrent assets 41,804  41,267  28,798  30,478  31,616 
Total assets 62,948  59,707  66,416  79,954  77,626 

Based on: 10-K (filing date: 2021-02-09), 10-K (filing date: 2020-02-12), 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Amgen Inc.’s current assets decreased from 2018 to 2019 but then slightly increased from 2019 to 2020.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Amgen Inc.’s property, plant and equipment, net decreased from 2018 to 2019 and from 2019 to 2020.
Noncurrent assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Amgen Inc.’s noncurrent assets increased from 2018 to 2019 and from 2019 to 2020.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Amgen Inc.’s total assets decreased from 2018 to 2019 but then slightly increased from 2019 to 2020.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Amgen Inc.’s cash and cash equivalents decreased from 2018 to 2019 but then slightly increased from 2019 to 2020.
Marketable securities Amount of investment in marketable security, classified as current. Amgen Inc.’s marketable securities decreased from 2018 to 2019 but then slightly increased from 2019 to 2020.
Trade receivables, net Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Amgen Inc.’s trade receivables, net increased from 2018 to 2019 and from 2019 to 2020.
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Amgen Inc.’s inventories increased from 2018 to 2019 and from 2019 to 2020.